(Q85309675)

English

Urodynamic effects of the combination of tamsulosin and daily tadalafil in men with lower urinary tract symptoms secondary to benign prostatic hyperplasia: a randomized, placebo-controlled clinical trial

scientific article published on 30 October 2012

In more languages

default for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23108604%20AND%20SRC:MED&resulttype=core&format=json

16 February 2020

Urodynamic effects of the combination of tamsulosin and daily tadalafil in men with lower urinary tract symptoms secondary to benign prostatic hyperplasia: a randomized, placebo-controlled clinical trial (English)

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23108604%20AND%20SRC:MED&resulttype=core&format=json

16 February 2020

1 reference

based on heuristic

inferred from title

prostatic hypertrophy

1 reference

based on heuristic

inferred from title

author name string

Rommel Prata Regadas

1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23108604%20AND%20SRC:MED&resulttype=core&format=json

16 February 2020

Ricardo Reges

2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23108604%20AND%20SRC:MED&resulttype=core&format=json

16 February 2020

João Batista Gadelha Cerqueira

3

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23108604%20AND%20SRC:MED&resulttype=core&format=json

16 February 2020

Daniel Gabrielle Sucupira

4

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23108604%20AND%20SRC:MED&resulttype=core&format=json

16 February 2020

Iatagan Rocha Josino

5

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23108604%20AND%20SRC:MED&resulttype=core&format=json

16 February 2020

Emmanuel Almeida Nogueira

6

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23108604%20AND%20SRC:MED&resulttype=core&format=json

16 February 2020

Francisco Vagnaldo F Jamacaru

7

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23108604%20AND%20SRC:MED&resulttype=core&format=json

16 February 2020

Manoel Odorico de Moraes

8

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23108604%20AND%20SRC:MED&resulttype=core&format=json

16 February 2020

Lúcio Flávio Gonzaga Silva

9

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23108604%20AND%20SRC:MED&resulttype=core&format=json

16 February 2020

publication date

30 October 2012

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23108604%20AND%20SRC:MED&resulttype=core&format=json

16 February 2020

International Urology and Nephrology

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23108604%20AND%20SRC:MED&resulttype=core&format=json

16 February 2020

45

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23108604%20AND%20SRC:MED&resulttype=core&format=json

16 February 2020

1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23108604%20AND%20SRC:MED&resulttype=core&format=json

16 February 2020

39-43

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23108604%20AND%20SRC:MED&resulttype=core&format=json

16 February 2020

Good urodynamic practices: uroflowmetry, filling cystometry, and pressure-flow studies.

1 reference

https://pubmed.ncbi.nlm.nih.gov/23108604

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Tadalafil administered once daily for lower urinary tract symptoms secondary to benign prostatic hyperplasia: a dose finding study

1 reference

https://pubmed.ncbi.nlm.nih.gov/23108604

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Combination of doxazosin and sildenafil exerts an additive relaxing effect compared with each compound alone on human cavernosal and prostatic tissue

1 reference

https://pubmed.ncbi.nlm.nih.gov/23108604

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The mechanics of the urethra and of micturition

1 reference

https://pubmed.ncbi.nlm.nih.gov/23108604

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The nitric oxide pathway in the human prostate: clinical implications in men with lower urinary tract symptoms

1 reference

https://pubmed.ncbi.nlm.nih.gov/23108604

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Urodynamic effects of once daily tadalafil in men with lower urinary tract symptoms secondary to clinical benign prostatic hyperplasia: a randomized, placebo controlled 12-week clinical trial

1 reference

https://pubmed.ncbi.nlm.nih.gov/23108604

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Effects of phosphodiesterase inhibitors on tension induced by norepinephrine and accumulation of cyclic nucleotides in isolated human prostatic tissue

1 reference

https://pubmed.ncbi.nlm.nih.gov/23108604

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Characterization and functional role of androgen-dependent PDE5 activity in the bladder

1 reference

https://pubmed.ncbi.nlm.nih.gov/23108604

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Comparative efficacy assessment of tamsulosin vs. tamsulosin plus tadalafil in the treatment of LUTS/BPH. Pilot study

1 reference

https://pubmed.ncbi.nlm.nih.gov/23108604

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Combination of alfuzosin and tadalafil exerts an additive relaxant effect on human detrusor and prostatic tissues in vitro.

1 reference

https://pubmed.ncbi.nlm.nih.gov/23108604

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Sildenafil citrate improves erectile function and urinary symptoms in men with erectile dysfunction and lower urinary tract symptoms associated with benign prostatic hyperplasia: a randomized, double-blind trial

1 reference

https://pubmed.ncbi.nlm.nih.gov/23108604

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Long-term administration of BAY 41-2272 prevents bladder dysfunction in nitric oxide-deficient rats

1 reference

https://pubmed.ncbi.nlm.nih.gov/23108604

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Tadalafil for the treatment of lower urinary tract symptoms secondary to benign prostatic hyperplasia: pathophysiology and mechanism(s) of action

1 reference

https://pubmed.ncbi.nlm.nih.gov/23108604

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Pathophysiology of clinical benign prostatic hyperplasia

1 reference

https://pubmed.ncbi.nlm.nih.gov/23108604

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The association between lower urinary tract symptoms and erectile dysfunction in four centres: the UrEpik study

1 reference

https://pubmed.ncbi.nlm.nih.gov/23108604

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A randomised, placebo-controlled study to assess the efficacy of twice-daily vardenafil in the treatment of lower urinary tract symptoms secondary to benign prostatic hyperplasia

1 reference

https://pubmed.ncbi.nlm.nih.gov/23108604

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

AUA guideline on management of benign prostatic hyperplasia (2003). Chapter 1: Diagnosis and treatment recommendations

1 reference

https://pubmed.ncbi.nlm.nih.gov/23108604

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Sildenafil influences lower urinary tract symptoms.

1 reference

https://pubmed.ncbi.nlm.nih.gov/23108604

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1007/S11255-012-0317-7

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23108604%20AND%20SRC:MED&resulttype=core&format=json

16 February 2020

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23108604%20AND%20SRC:MED&resulttype=core&format=json

16 February 2020

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q85309675&oldid=1756387016"